Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 17, 2026 07:05 ET | Source: uniQure Inc.

uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease

~ 3-year analysis from the Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter...
April 30, 2026 07:05 ET | Source: uniQure Inc.

uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease

~ Submission of a UK Marketing Authorization Application for AMT-130 is expected in the third quarter of 2026 ~ ~ Type B Meeting with U.S. FDA granted in second quarter; expect to discuss potential...
November 26, 2019 05:00 ET | Source: Global Market Insights, Inc

Proanthocyanidins Market value to hit $12 billion by 2026: Global Market Insights, Inc.

Selbyville, Delaware, Nov. 26, 2019 (GLOBE NEWSWIRE) -- Global Proanthocyanidins Market revenue is expected to cross USD 12 billion by 2026, according to a new research report by Global Market...
January 07, 2019 07:07 ET | Source: Voyager Therapeutics, Inc.

Voyager Therapeutics Provides Updates for VY-AADC Clinical Program for Parkinson’s Disease

Voyager to increase the size of RESTORE-1 Phase 2 trial and to conduct a similarly-sized RESTORE-2 Phase 3 trial VY-AADC clinical program updates incorporate FDA feedback from Type B meeting ...